Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Gains from Investment Securities (2021 - 2026)

Krystal Biotech (KRYS) has disclosed Gains from Investment Securities for 5 consecutive years, with $4.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $4.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Dec 2025, changed N/A year-over-year, with the annual reading at $6.0 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities hit $4.2 million in Q4 2025 for Krystal Biotech, up from -$8000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.2 million in Q4 2025 to a low of -$3.9 million in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $496333.3 across 5 years, with a median of $809000.0 in 2023.
  • Biggest YoY gain for Gains from Investment Securities was 338.1% in 2023; the steepest drop was 498.77% in 2023.
  • Year by year, Gains from Investment Securities stood at $1.5 million in 2021, then crashed by 143.5% to -$649000.0 in 2022, then crashed by 498.77% to -$3.9 million in 2023, then grew by 26.43% to -$2.9 million in 2024, then surged by 245.47% to $4.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for KRYS at $4.2 million in Q4 2025, -$8000.0 in Q2 2025, and $1.8 million in Q1 2025.